As of 2024-12-12, the Intrinsic Value of Promore Pharma AB (PROMO.ST) is
-1.89 SEK. This PROMO.ST valuation is based on the model Peter Lynch Fair Value.
With the current market price of 9.70 SEK, the upside of Promore Pharma AB is
-119.47%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-1.89 SEK
Intrinsic Value
PROMO.ST Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-1.89 - -1.89 |
-1.89 |
-119.47% |
| P/E |
(837.20) - (1,089.00) |
(1,034.84) |
-10768.4% |
| DDM - Stable |
(451.35) - 2,503.70 |
1,026.17 |
10479.1% |
| DDM - Multi |
(504.75) - 2,310.32 |
(1,352.03) |
-14038.5% |
PROMO.ST Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
6.20 |
| Beta |
-0.77 |
| Outstanding shares (mil) |
0.64 |
| Enterprise Value (mil) |
1.74 |
| Market risk premium |
5.50% |
| Cost of Equity |
6.14% |
| Cost of Debt |
5.00% |
| WACC |
5.90% |